✦ LIBER ✦

P11. Differing mechanisms of hypercalcaemia in patients with early and advanced humoral hypercalcaemia of malignancy

✍ Scribed by Ralston, SH; Boyce, BF; Cowan, RA; Gardner, MD; Fraser, WD; Boyle, IT

Book ID: 122638281
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 140 KB
Volume: 9
Category: Article
ISSN: 8756-3282
DOI: 10.1016/8756-3282(88)90077-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Raised plasma PTHrP and immunohistochemi

Raised plasma PTHrP and immunohistochemical tissue localisation in a patient with humoral hypercalcaemia of malignancy

✍ Grill, V.; Ho, P.; Ebeling, P.; Danks, J.; Moseley, J.; Martin, T.J. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Optimal frequency of administration of p

Optimal frequency of administration of pamidronate in patients with hypercalcaemia of malignancy

✍ Sunil J. Wimalawansa* 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

NOD/SCID mouse model of canine T-cell ly

NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging

✍ M. V. P. Nadella; W. C. Kisseberth; K. S. Nadella; N. K. Thudi; D. H. Thamm; E. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 722 KB

Treatment of tumour-induced hypercalcaem

Treatment of tumour-induced hypercalcaemia in advanced breast cancer patients with three different doses of disodium pamidronate adapted to the initial level of calcaemia

✍ Z. Neškovié-Konstantinovié; L. Mitrovié; J. Petrovié; L. Stamatovié; Z. Ristovié 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

A group of 38 female patients with advanced breast cancer experiencing the first occurrence of tumour-induced hypercalcaemia (TIH), mostly with osteolytic progressive bone metastases, were included in a prospective calcaemiaadapted study using three different doses of pamidronate (30 mg, 45 mg and 6

13. The effects of aminohydroxypropylidi

13. The effects of aminohydroxypropylidine bisphosphonate (APD) on calcium, PTH 1–84 and nephrogenous cAMP in patients with hypercalcaemia of malignancy (HCM) and Paget's disease of bone

✍ Fraser, WD; Logue, FC; O'Reilly, DStJ; Beastall, GH; Gallacher, S; Patel, U; Ral 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 136 KB

The humoral immune response to p53 in pa

The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the α-fetoprotein status

✍ Martin Volkmann; Martina Müller; Walter J. Hofmann; Martina Meyer; Jens Hagelste 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 795 KB

Recently, p53 gene aberrations have been recognized as a relevant factor in hepatocarcinogenesis, in tumors from both high-risk and low-risk areas. Because p53 gene mutations typically result in increased p53 levels in tumor cells, this cellular protein might become immunogenic during tumor developm